Dolby Laboratories, Inc.
DLB
$61.06
-$3.44-5.33%
NYSE
| 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.37% | -15.77% | 19.84% | -6.17% | 1.26% |
| Total Depreciation and Amortization | 6.41% | 0.79% | 15.05% | 17.57% | 20.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.95% | 81.69% | 63.54% | -6.80% | 34.29% |
| Change in Net Operating Assets | -247.75% | -2,862.04% | 51.25% | -6.40% | 84.04% |
| Cash from Operations | -48.68% | 5.73% | 218.34% | -3.59% | 1,169.82% |
| Capital Expenditure | 31.73% | -120.14% | 15.57% | 22.64% | -11.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -102.42% | 100.00% | 277.64% | -- |
| Cash from Investing | 115.29% | 91.61% | 16.99% | 244.88% | -1,386.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -35.67% | 600.56% | 23.81% | -64.08% | 16.47% |
| Repurchase of Common Stock | -113.32% | -71.30% | -13.25% | -38.81% | 58.59% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.85% | -10.42% | -10.21% | -10.84% | -10.49% |
| Other Financing Activities | 26.08% | 96.24% | 86.47% | -- | 29.32% |
| Cash from Financing | -111.62% | -6.55% | -4.01% | -46.90% | 53.99% |
| Foreign Exchange rate Adjustments | 99.93% | -101.53% | 764.88% | 175.22% | -205.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -294.06% | 118.32% | 113.61% | 19.87% | 131.02% |